FilingSEC EDGAR8-K
TELA Bio Receives Approval for Reverse Stock Split but Defers Implementation
· SEC accepted
StageImplementation Deferred
Filing content
TELA Bio received stockholder approval for a reverse stock split but decided not to implement it after regaining compliance with Nasdaq listing requirements.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…